Wakefulness

Wakefulness is a state of sustained alertness and reduced drive to sleep.

As a drug effect it is acute and dose-proportional, fading as the substance wears off; this sets it apart from a clinical sleep disorder. It ranges from a mild sharpening of attention to complete sleep suppression lasting many hours, and while often sought, it becomes aversive when the body needs rest.

It is among the most consistently reported effects across psychoactive substances. Most commonly induced at moderate to high doses under psychedelics such as LSD, psilocybin mushrooms, and DMT, and under stimulants such as amphetamine, MDMA, and modafinil; it also appears under nootropics such as aniracetam and meclofenoxate, and in a more agitated form under deliriants such as diphenhydramine and datura.

Wakefulness is felt as an insistent, forward-leaning alertness: the mind turns over readily, attention shifts from object to object without any pull toward rest. Sleep feels unnecessary or impossible rather than simply deferred.

It commonly comes with a mild elevation in heart rate, slight tension in the eyes and jaw, and a sense that the body is running above its resting baseline. Noticing the alertness tends to sharpen it — attempts to wind down can feel futile. At higher doses under stimulants, the alertness becomes restless and difficult to settle.

Wakefulness arises through different pathways depending on the drug class:

• Psychedelics — act on 5-HT2A receptors, increasing cortical arousal and disrupting the normal progression toward sleep onset.
• Stimulants — elevate synaptic dopamine and norepinephrine, driving sympathetic activation that directly suppresses sleep drive.
• Nootropics — modulate acetylcholine systems, supporting alert cognitive states with less pronounced sympathetic activation.
• Deliriants — block muscarinic acetylcholine receptors; the resulting CNS disruption produces agitated wakefulness alongside confusion.

How much each pathway contributes in a given case is not fully understood.

Who experiences it, and how strongly, varies widely. Higher doses raise both intensity and duration; tolerance to stimulants develops quickly with repeated use, blunting the effect over time.

Set and setting matter less here than with some effects — wakefulness is largely pharmacological — but stimulating environments amplify it, especially under psychedelics and stimulants. Going in intending to stay alert tends to reinforce it. Prior sleep deprivation and high baseline arousal can make it more pronounced even at modest doses.